Published in J Virol on December 01, 1997
A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell (2009) 2.64
Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol (1998) 2.28
Virus-specific CD8+ lymphocytes share the same effector-memory phenotype but exhibit functional differences in acute hepatitis B and C. J Virol (2002) 2.26
Ovca1 regulates cell proliferation, embryonic development, and tumorigenesis. Genes Dev (2004) 2.04
Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol (1999) 1.63
Interaction of hepatitis C virus core protein with viral sense RNA and suppression of its translation. J Virol (1999) 1.63
Hepatitis C virus core protein-induced loss of LZIP function correlates with cellular transformation. EMBO J (2000) 1.49
Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol (1999) 1.45
Intramembrane proteolysis and endoplasmic reticulum retention of hepatitis C virus core protein. J Virol (2004) 1.40
Rubella virus capsid associates with host cell protein p32 and localizes to mitochondria. J Virol (2000) 1.32
Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors. J Virol (1998) 1.29
Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 1.22
Essential role of TNF family molecule LIGHT as a cytokine in the pathogenesis of hepatitis. J Clin Invest (2006) 1.20
Hepatitis C virus core protein suppresses NF-kappaB activation and cyclooxygenase-2 expression by direct interaction with IkappaB kinase beta. J Virol (2005) 1.16
Molecular genetics of hepatocellular neoplasia. Am J Transl Res (2010) 1.16
Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1. J Virol (2000) 1.14
Hepatitis C virus structural proteins impair dendritic cell maturation and inhibit in vivo induction of cellular immune responses. J Virol (2003) 1.13
Identification of residues in the hepatitis C virus core protein that are critical for capsid assembly in a cell-free system. J Virol (2005) 1.08
HCV core protein uses multiple mechanisms to induce oxidative stress in human hepatoma Huh7 cells. Viruses (2015) 0.96
Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J Virol (2001) 0.94
Upregulation of lymphotoxin beta expression in liver progenitor (oval) cells in chronic hepatitis C. Gut (2003) 0.92
Transcriptional activation of the interleukin-2 promoter by hepatitis C virus core protein. J Virol (2001) 0.92
A transgenic mouse model of steatosis and hepatocellular carcinoma associated with chronic hepatitis C virus infection in humans. Trans Am Clin Climatol Assoc (2000) 0.85
Tumor necrosis factor receptor 1 expression is upregulated in dendritic cells in patients with chronic HCV who respond to therapy. Hepat Res Treat (2010) 0.84
Lymphotoxin signaling is initiated by the viral polymerase in HCV-linked tumorigenesis. PLoS Pathog (2013) 0.83
B-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling. PLoS One (2014) 0.81
Interaction between hepatitis C virus core protein and translin protein--a possible molecular mechanism for hepatocellular carcinoma and lymphoma caused by hepatitis C virus. World J Gastroenterol (2003) 0.81
Transactivating effect of hepatitis C virus core protein: a suppression subtractive hybridization study. World J Gastroenterol (2004) 0.81
Hepatitis C virus non-structural 5A protein can enhance full-length core protein-induced nuclear factor-kappaB activation. World J Gastroenterol (2005) 0.80
The evaluation of hepatitis C virus core antigen in immunized BALB/c mice. Hepat Mon (2012) 0.78
Lymphotoxin in physiology of lymphoid tissues - Implication for antiviral defense. Cytokine (2016) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology (1973) 127.36
Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 37.89
An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science (1989) 18.79
Apoptosis by death factor. Cell (1997) 14.42
An essential role for NF-kappaB in preventing TNF-alpha-induced cell death. Science (1996) 13.87
NF-kappa B: ten years after. Cell (1996) 12.80
Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science (1996) 12.23
Unraveling function in the TNF ligand and receptor families. Science (1994) 10.83
Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell (1993) 9.84
FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell (1995) 9.81
Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappaB activation prevents cell death. Cell (1996) 9.68
The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death. Cell (1994) 9.25
TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell (1996) 8.89
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell (1995) 8.80
A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med (1992) 8.06
NF-kappa B: a lesson in family values. Cell (1995) 7.33
Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science (1994) 7.10
Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature (1993) 7.10
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci U S A (1990) 6.96
TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40. Science (1995) 6.41
Characterization of the hepatitis C virus-encoded serine proteinase: determination of proteinase-dependent polyprotein cleavage sites. J Virol (1993) 6.36
Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev (1993) 6.02
The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell (1995) 5.97
A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell (1994) 5.94
TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity (1996) 5.45
Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of hepatitis C virus. J Virol (1993) 5.41
NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J Virol (1993) 4.60
Nonstructural protein 3 of the hepatitis C virus encodes a serine-type proteinase required for cleavage at the NS3/4 and NS4/5 junctions. J Virol (1993) 4.57
The 19-kilodalton adenovirus E1B transforming protein inhibits programmed cell death and prevents cytolysis by tumor necrosis factor alpha. Mol Cell Biol (1992) 4.17
Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc Natl Acad Sci U S A (1997) 3.88
Two tumour necrosis factor receptors: structure and function. Trends Cell Biol (1995) 3.67
Regulation of apoptosis by viral gene products. J Virol (1997) 3.67
Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini. J Virol (1994) 3.61
Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med (1993) 3.51
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif. J Clin Invest (1995) 3.47
Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet (1989) 3.42
Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature (1994) 3.34
Viruses and apoptosis. Curr Opin Genet Dev (1995) 3.26
Biosynthesis and biochemical properties of the hepatitis C virus core protein. J Virol (1994) 3.19
Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. J Gen Virol (1993) 3.18
Essential roles of the Fas ligand in the development of hepatitis. Nat Med (1997) 3.05
Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet (1989) 2.94
Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J Biol Chem (1995) 2.78
A lymphotoxin-beta-specific receptor. Science (1994) 2.73
High prevalence of thyroid autoantibodies in a prospective series of patients with chronic hepatitis C before interferon therapy. Hepatology (1993) 2.65
Tumor necrosis factor ligand superfamily: involvement in the pathology of malignant lymphomas. Blood (1995) 2.57
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J Virol (1993) 2.57
Virus proteins that counteract host immune defenses. Cell (1992) 2.51
Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Lancet (1992) 2.51
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients. J Virol (1996) 2.47
Virus-triggered acquired immunodeficiency by cytotoxic T-cell-dependent destruction of antigen-presenting cells and lymph follicle structure. Proc Natl Acad Sci U S A (1991) 2.41
Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules. J Virol (1995) 2.34
The ligands and receptors of the lymphotoxin system. Curr Top Microbiol Immunol (1995) 2.32
TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor. J Biol Chem (1996) 2.23
A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor. Cell (1988) 2.20
Tumor necrosis factors: developments during the last decade. Eur Cytokine Netw (1996) 2.18
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Fas antigen and p55 TNF receptor signal apoptosis through distinct pathways. J Immunol (1994) 2.06
Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol (1996) 2.02
Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene (1996) 1.96
Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol (1995) 1.87
Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor. J Virol (1997) 1.84
Hepatitis C virus antibodies in southern African blacks with hepatocellular carcinoma. Lancet (1990) 1.83
Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology (1994) 1.80
Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein. Mol Cell Biol (1995) 1.76
Differential subcellular localization of hepatitis C virus core gene products. Virology (1995) 1.73
Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol (1994) 1.72
The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells. J Virol (1991) 1.65
Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines. J Exp Med (1996) 1.62
Induction by E1A oncogene expression of cellular susceptibility to lysis by TNF. Nature (1988) 1.62
Adenovirus E1A renders infected cells sensitive to cytolysis by tumor necrosis factor. J Immunol (1989) 1.59
Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein. Virus Res (1995) 1.58
Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein. Virology (1997) 1.49
Suppression of apoptotic cell death by hepatitis C virus core protein. Virology (1996) 1.46
Interaction between hepatitis C virus core protein and E1 envelope protein. J Virol (1996) 1.39
Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol (1995) 1.27
Aggregation of the intracellular domain of the type 1 tumor necrosis factor receptor defined by the two-hybrid system. J Biol Chem (1994) 1.19
Hepatitis C virus and Sjögren's syndrome. Lancet (1992) 1.19
In situ detection of beta-galactosidase in lenses of transgenic mice with a gamma-crystallin/lacZ gene. Science (1987) 1.16
Recent advances in tumor necrosis factor and CD40 signaling. Curr Opin Genet Dev (1996) 1.09
Adenovirus E3-10.4K/14.5K protein complex inhibits tumor necrosis factor-induced translocation of cytosolic phospholipase A2 to membranes. J Virol (1997) 1.08
Lymphotoxin beta receptor triggering induces activation of the nuclear factor kappaB transcription factor in some cell types. J Biol Chem (1996) 1.07
Hepatitis C virus and autoimmunity: fortuitous association or reality? Gastroenterology (1994) 1.01
Control of Ha-ras-mediated mammalian cell transformation by Escherichia coli regulatory elements. Cancer Res (1992) 0.97
Hepatitis C virus-specific T lymphocyte responses. Curr Opin Immunol (1995) 0.90
Preparation and characterization of soluble recombinant heterotrimeric complexes of human lymphotoxins alpha and beta. J Biol Chem (1996) 0.89
Construction and evaluation of a hncDNA library of human 12p transcribed sequences derived from a somatic cell hybrid. Genomics (1993) 0.83
Improved gene expression by a modified bicistronic retroviral vector. Biochem Biophys Res Commun (1995) 0.78
Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol (2001) 8.95
Jasmonic acid carboxyl methyltransferase: a key enzyme for jasmonate-regulated plant responses. Proc Natl Acad Sci U S A (2001) 2.84
Synergistic enhancement of nuclear receptor function by p160 coactivators and two coactivators with protein methyltransferase activities. J Biol Chem (2001) 2.74
Controlled delivery systems for proteins based on poly(lactic/glycolic acid) microspheres. Pharm Res (1991) 2.70
Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem (1995) 2.43
Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. J Nerv Ment Dis (1990) 2.42
The helicase activity associated with hepatitis C virus nonstructural protein 3 (NS3). J Virol (1996) 2.30
Expression of genes introduced into cells by retroviral infection is more efficient than that of genes introduced into cells by DNA transfection. J Virol (1984) 2.28
The genital mycoplasmas. N Engl J Med (1973) 2.21
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion. J Clin Invest (1992) 2.20
Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells. J Virol (1993) 2.16
Minocycline: Possible vestibular side-effects. Lancet (1974) 2.09
Methodologic investigations and prevalence of genital mycoplasmas in pregnancy. J Infect Dis (1970) 2.02
Glutathione S-transferase mu modulates the stress-activated signals by suppressing apoptosis signal-regulating kinase 1. J Biol Chem (2001) 1.99
Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem (1998) 1.94
My children and me: midlife evaluations of grown children and of self. Psychol Aging (1994) 1.90
Absence of infection in breast-fed infants born to hepatitis C virus-infected mothers. J Pediatr (1995) 1.67
Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) (2005) 1.65
Hepatitis C virus core protein interacts with cellular putative RNA helicase. J Virol (1999) 1.63
leafy hull sterile1 is a homeotic mutation in a rice MADS box gene affecting rice flower development. Plant Cell (2000) 1.62
Anticarcinogenic effect of Panax ginseng C.A. Meyer and identification of active compounds. J Korean Med Sci (2001) 1.62
Multiple forms of anthranilate synthetase-anthranilate 5-phosphoribosylpyrophosphate phosphoribosyltransferase from Salmonella typhimurium. J Biol Chem (1971) 1.57
Sexual activity and vaginal colonization with genital mycoplasmas. JAMA (1972) 1.57
Targeted disruption of the microsomal epoxide hydrolase gene. Microsomal epoxide hydrolase is required for the carcinogenic activity of 7,12-dimethylbenz[a]anthracene. J Biol Chem (1999) 1.54
Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem (1996) 1.53
Tumor-induced immunosuppression: a barrier to immunotherapy of large tumors by cytokine-secreting tumor vaccine. Hum Gene Ther (2000) 1.53
Agrobacterium tumefaciens-mediated transformation of the plant pathogenic fungus, Magnaporthe grisea. Mol Cells (2001) 1.51
C/EBPbeta, when expressed from the C/ebpalpha gene locus, can functionally replace C/EBPalpha in liver but not in adipose tissue. Mol Cell Biol (2000) 1.49
Birth weight and genital mycoplasmas in pregnancy. N Engl J Med (1971) 1.48
Increased expression of inflammation-related genes in cultured preadipocytes/stromal vascular cells from obese compared with non-obese Pima Indians. Diabetologia (2005) 1.47
A collagen-like peptide stimulates tyrosine phosphorylation of syk and phospholipase C gamma2 in platelets independent of the integrin alpha2beta1. Blood (1997) 1.45
Analysis of genes expressed during rice-Magnaporthe grisea interactions. Mol Plant Microbe Interact (2001) 1.45
Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol (1999) 1.45
Paraffinoma of the penis. Yonsei Med J (1994) 1.45
Intradiverticular tumors of the bladder: surgical implications--an eleven-year review. Eur Urol (1993) 1.44
Complete membranous obstruction of the inferior vena cava treated successfully by King's bioptome and balloon angioplasty. Am J Cardiol (1993) 1.40
Microbiological investigation of Bartholin's gland abscesses and cysts. Am J Obstet Gynecol (1977) 1.35
Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol (1998) 1.32
Neoplastic transformation and tumorigenesis associated with overexpression of phospholipase D isozymes in cultured murine fibroblasts. Carcinogenesis (2001) 1.29
Rupture of the rectosigmoid colon with evisceration of the small bowel through the anus. Yonsei Med J (2000) 1.29
Sexual experience and urethral colonization with genital mycoplasmas. A study in normal men. Ann Intern Med (1973) 1.28
Ginsenoside-Rg1, one of the major active molecules from Panax ginseng, is a functional ligand of glucocorticoid receptor. Mol Cell Endocrinol (1997) 1.27
Modulation of the trans-suppression activity of hepatitis C virus core protein by phosphorylation. J Virol (1995) 1.27
Structure-based mutational analysis of the hepatitis C virus NS3 helicase. J Virol (2001) 1.26
Drugs derived from cannabinoids. 5. delta6a,10a-Tetrahydrocannabinol and heterocyclic analogs containing aromatic side chains. J Med Chem (1976) 1.26
Direct interaction of two homeoproteins, homothorax and extradenticle, is essential for EXD nuclear localization and function. Mech Dev (2000) 1.25
Structural modification of lignocellulosics by pretreatments to enhance enzymatic hydrolysis. Biotechnol Bioeng (1983) 1.23
Ginsenoside Rh4, a genuine dammarane glycoside from Korean red ginseng. Planta Med (1996) 1.22
Silica stone--development due to long time oral trisilicate intake. Scand J Urol Nephrol (1993) 1.22
Community study of depression in old age in Taiwan: prevalence, life events and socio-demographic correlates. Br J Psychiatry (2001) 1.22
Acute pelvic inflammatory disease: characteristics of patients with gonococcal and nongonococcal infection and evaluation of their response to treatment with aqueous procaine penicillin G and spectinomycin hydrochloride. Sex Transm Dis (1978) 1.19
In vitro and in vivo antitumoral phenanthrenes from the aerial parts of Dendrobium nobile. Planta Med (1995) 1.17
The anthranilate synthetase-anthranilate 5-phosphoribosylpyrophosphate phosphoribosyltransferase aggregate. Purification of the aggregate and regulatory properties of anthranilate synthetase. J Biol Chem (1970) 1.17
Abalone sperm lysin: unusual mode of evolution of a gamete recognition protein. Zygote (1993) 1.16
Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int J Oncol (2000) 1.15
Medullary nephrocalcinosis associated with long-term furosemide abuse in adults. Nephrol Dial Transplant (2001) 1.14
Angiopoietin-1 inhibits irradiation- and mannitol-induced apoptosis in endothelial cells. Circulation (2000) 1.14
Caspase 3-mediated cleavage of p21WAF1/CIP1 associated with the cyclin A-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in SK-HEP-1 cells. J Biol Chem (2000) 1.13
Three-vessel view of the fetal upper mediastinum: an easy means of detecting abnormalities of the ventricular outflow tracts and great arteries during obstetric screening. Ultrasound Obstet Gynecol (1997) 1.12
Cellular immune response to HBcAg in mother-to-infant transmission of hepatitis B virus. Hepatology (1992) 1.12
The nucleolar phosphoprotein B23 interacts with hepatitis delta antigens and modulates the hepatitis delta virus RNA replication. J Biol Chem (2001) 1.12
Prenatal diagnosis of placenta previa accreta by transabdominal color Doppler ultrasound. Ultrasound Obstet Gynecol (2000) 1.11
Familial aggregation of blood pressures of newborn infants and their mother. Pediatrics (1976) 1.11
Bcl-2 overexpression attenuates resveratrol-induced apoptosis in U937 cells by inhibition of caspase-3 activity. Carcinogenesis (2001) 1.11
Phospholipase C-delta1 is activated by capacitative calcium entry that follows phospholipase C-beta activation upon bradykinin stimulation. J Biol Chem (1999) 1.10
Bovine spongiform encephalopathy: the effect of oral exposure dose on attack rate and incubation period in cattle. J Gen Virol (2007) 1.10
Susceptibility of Enterobacter aerogenes and Enterobacter cloacae to 19 antimicrobial agents in vitro. Am J Med Sci (1970) 1.09
Comparison of methods for the isolation of genital mycoplasmas from men. J Infect Dis (1976) 1.09
Plasma secretin concentrations in fasting and postprandial state in man. Am J Dig Dis (1978) 1.09
Fibrovascular polyp of the esophagus in infant. Yonsei Med J (2001) 1.09
Cytochrome P450 family 4 in a cockroach: molecular cloning and regulation by regulation by hypertrehalosemic hormone. Proc Natl Acad Sci U S A (1991) 1.08
Nonenhancing intramedullary astrocytomas and other MR imaging features: a retrospective study and systematic review. AJNR Am J Neuroradiol (2009) 1.06
A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials (2002) 1.06
Positive Darwinian selection on two homologous fertilization proteins: what is the selective pressure driving their divergence? J Mol Evol (1997) 1.06
Psychiatric epidemiology in Korea. Part II: Urban and rural differences. J Nerv Ment Dis (1990) 1.06
A viral double-stranded RNA up regulates the fungal virulence of Nectria radicicola. Mol Plant Microbe Interact (2001) 1.05
The effects of anti-ulcer agents on indomethacin-induced gastric ulceration in the rat. Arch Int Pharmacodyn Ther (1971) 1.04
Ribavirin enhancement of hepatitis C virus core antigen-specific type 1 T helper cell response correlates with the increased IL-12 level. J Hepatol (2000) 1.04
Effect on birth weight of erythromycin treatment of pregnant women. Obstet Gynecol (1987) 1.03
Improved gene expression by a U3-based retroviral vector. Biochem Biophys Res Commun (1992) 1.02
Diagnosis and control measures of the 2010 outbreak of foot-and-mouth disease A type in the Republic of Korea. Transbound Emerg Dis (2012) 1.02
Sex-specific control of Drosophila melanogaster yolk protein 1 gene expression is limited to transcription. Mol Cell Biol (1988) 1.01
Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia (1996) 1.01
A new arterial flap from the postauricular surface: its anatomic basis and clinical application. Plast Reconstr Surg (1988) 1.01
Reversibility of ethambutol optic neuropathy. J Ocul Pharmacol Ther (1997) 1.00
Crystallization and preliminary crystallographic analysis of the proline dehydrogenase domain of the multifunctional PutA flavoprotein from Escherichia coli. Acta Crystallogr D Biol Crystallogr (2001) 1.00
Cellular redistribution of PKCalpha, rhoA, and ROKalpha following smooth muscle agonist stimulation. Exp Cell Res (1999) 1.00
Co-operation between protein-acetylating and protein-methylating co-activators in transcriptional activation. Biochem Soc Trans (2000) 1.00
Chorioamnionitis and colonization of the newborn infant with genital mycoplasmas. N Engl J Med (1975) 1.00
Two forms of phospholipase C-beta 1 generated by alternative splicing. J Biol Chem (1994) 0.99
Copper transfer and activation of the Streptomyces apotyrosinase are mediated through a complex formation between apotyrosinase and its trans-activator MelC1. J Biol Chem (1992) 0.99
Recurrence rate and risk factors for urinary calculi after extracorporeal shock wave lithotripsy. J Urol (1996) 0.98
Replantation and revascularization of hands: clinical analysis and functional results of 261 cases. J Hand Surg Am (1989) 0.98
Extracellular autoprocessing of a metalloprotease from Streptomyces cacaoi. J Biol Chem (1992) 0.98
ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy. Acta Biochim Pol (2000) 0.98
Ginsenoside-Rg5 suppresses cyclin E-dependent protein kinase activity via up-regulating p21Cip/WAF1 and down-regulating cyclin E in SK-HEP-1 cells. Anticancer Res (1997) 0.98
Renal angiomyolipoma: selective arterial embolization--effectiveness and changes in angiomyogenic components in long-term follow-up. Radiology (1997) 0.97
The association between the PTPN22 C1858T polymorphism and systemic lupus erythematosus: a meta-analysis update. Lupus (2010) 0.96
Physicochemical evidence that Treponema pallidum TroA is a zinc-containing metalloprotein that lacks porin-like structure. J Bacteriol (1999) 0.96